XBB.1.16 variant 'new kid on the block', could be driving recent rise in Covid cases: Dr Randeep GuleriaNew variants will keep coming as the virus keeps on mutating over the time and the XBB 1.16 is sort of a "new kid on the block", Guleria sa...
Ex-AIIMS chief warns: Influenza virus H3N2 can spread like COVID, elderly be carefulFormer AIIMS chief Dr Randeep Guleria said that we seeing more cases of Influenza virus H3N2 because as the virus mutates a little bit, the...
Former AIIMS Director Randeep Guleria joins Medanta HospitalRecipient of Padma Shri and Dr B.C. Roy Award, former AIIMS Delhi director is globally renowned for his vast experience and exceptional con...
M Srinivas appointed Director of AIIMS-DelhiDr Srinivas will succeed Randeep Guleria who has been holding the post since March 2017. Srinivas was a professor in the Department of Pedi...
COVID-19 vaccines can be tweaked for protection against new variants: AIIMS director Dr Randeep Guleria"Although there is this new variant of COVID-19, the silver lining is that it does seem to be a milder disease and we should have protectio...
Virus will not mutate "dramatically" in the forthcoming months: Randeep Guleria on Covid 19While a large section of the Indian population is scarred by the havoc caused during the second wave of COVID-19 a few months ago, many exp...
Third-wave may not come if COVID norms are followed, vaccination done properly: AIIMS director"That depends on how we behave, if we are careful and we have good vaccination coverage, then the third wave may not come, or it will be ve...
India likely to have COVID vaccine for children above 2 years by September-October: AIIMS DirectorIn an interview with ANI, Dr Guleria said that Covaxin's data for children after completion of phase two or three trials is expected by Sep...
Remdesivir not magic bullet, does not reduce mortality, say health expertsAddressing the media, AIIMS Director Dr Randeep Guleria said remdesivir should only be given to patients hospitalised with moderate illness...
Situation grim, we’re staring at another full-blown crisis: Randeep GuleriaTill about a month ago, Delhi was recording 130 to 140 cases daily. However, in the last one week, the daily tally has increased 10 times. ...
Vaccine antibodies will last at least 8 months: AIIMS chiefDr Guleria added that after two doses, “you are protected. But protecting others would need you to follow Covid-appropriate behaviour”. He ...
5 Covid vaccines undergoing trial in India logistically feasible for distribution in both urban, rural areas: AIIMS directorDr Guleria expressed hope that by the end of this month or early next month, at least one of the five vaccines being locally-tested should ...
Chennai trial finding is incidental rather than related to vaccine: AIIMS Director"There is good data available that the vaccines are very safe. Safety and efficacy of vaccine not compromised at all. About 70,000-80,000 v...
Long-term health effects due to styrene vapour exposure small: AIIMS directorAs far as treatment is concerned, there is no specific antidote or a definite medicine for reversing the effect of this compound.The therap...
COVID-19 is likely to peak in June-July: Randeep GuleriaNew Delhi [India], May 7 (ANI) As per the modeling data and the way India's COVID-19 cases are increasing, it is likely that peak can come ...
'Govt using telemedicine to reduce doctors’ exposure'Details of patients, who are otherwise healthy, are sent to doctors who then advise workers on how to manage the patients
Dr Randeep Guleria is new director of AIIMS-DelhiDr Guleria joined AIIMS as an assistant professor in 1992 and has been the HoD of the department of pulmonary medicine and sleep disorders.